Caesarstone Ltd. (CSTE) - Form 20-F Summary
Business Context and Reporting Period
Company: Caesarstone Ltd.
Reporting Period: Fiscal Year Ended December 31, 2025
Business Overview: A global designer, producer, and reseller of engineered stone, porcelain, and natural stone surfaces, primarily for countertops. The company operates in approximately 60 countries with major markets in the U.S., Australia, Canada, and Israel. In 2025, the company completed the closure of its Bar-Lev manufacturing facility in Israel and fully acquired Lioli Ceramica Pvt. Ltd. in India, shifting its engineered stone production almost entirely to third-party Production Business Partners (PBPs).
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 (USD) | 2024 (USD) | Change |
|---|---|---|---|
| Revenue | $397.2 million | $443.2 million | -10.4% |
| Gross Profit | $73.3 million | $96.7 million | -24.2% |
| Gross Margin | 18.4% | 21.8% | -340 bps |
| Net Loss (GAAP) | $(137.5) million | $(42.8) million | Worsened |
| Adjusted EBITDA | $(32.6) million | $(11.5) million | Worsened |
| Cash & Equivalents | $58.4 million | $57.3 million | +1.9% |
| Debt (Short-term) | $2.9 million | $4.6 million | -37.0% |
Note: The Net Loss includes significant non-cash impairment charges and legal settlement provisions.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 10.4% year-over-year, driven by lower sales volumes and average selling prices (ASP) due to macroeconomic headwinds, competitive pressures, and the Australian ban on crystalline silica-containing engineered stone.
- Margin Compression: Gross margin declined to 18.4% from 21.8%. This was caused by lower capacity utilization at the Bar-Lev plant prior to closure, increased logistics costs, and tariffs on U.S. imports, partially offset by a higher mix of lower-cost PBP-sourced products.
- Impairment Charges: The company recorded $45.7 million in impairment charges related to the closure of the Bar-Lev facility, the Richmond Hill facility (held for sale), and associated right-of-use assets.
- Legal Provisions: Legal settlements and loss contingencies increased to $25.6 million from $7.2 million, primarily due to silicosis-related claims in the U.S. and Australia.
- Geographic Performance: U.S. revenue fell 14.9%, Australia fell 10.5%, and Canada fell 16.0%. EMEA revenue grew 10.3% due to improved market conditions.
Guidance, Outlook, and Risks
Outlook & Strategy: Management expects to rely on PBPs for substantially all engineered stone production in 2026. The company is focusing on cost optimization, expanding sales in the U.S. (particularly the South and Southeast), and developing silica-free alternative materials (Caesarstone ICON) to comply with evolving regulations.
Key Risks & Contingencies:
- Silicosis Litigation: The company faces 618 lawsuits globally (427 in the U.S., 151 in Australia, 40 in Israel). A provision of $47.3 million has been recorded for probable losses. Insurance coverage for U.S. claims is disputed, and no receivable has been recognized for U.S. claims due to uncertainty.
- Regulatory Bans: Australia implemented a ban on engineered stone containing crystalline silica in July 2024. Similar regulatory actions are being considered in California and other jurisdictions, which could materially impact demand for traditional quartz products.
- Trade & Tariffs: The company faces exposure to U.S. tariffs and potential safeguard investigations (Section 201) on quartz surface products, which could increase costs or limit market access.
- Share Price Volatility: The stock price fell below the $1.00 Nasdaq minimum listing requirement in November 2025, reaching a low of $0.86. The company is in a grace period to regain compliance.
- Geopolitical Instability: Operations in Israel are subject to risks from regional conflict, including potential workforce disruptions and supply chain interruptions.
Investor Verification Checklist
- Insurance Recoverability: Verify the status of the declaratory judgment actions with U.S. insurers regarding silica coverage, as the $11.0 million insurance receivable relates primarily to Australia and Israel, with U.S. coverage currently unrecognized.
- Asset Realization: Monitor the progress of selling the Richmond Hill facility and subleasing the Sdot-Yam facility to offset lease liabilities and impairment losses.
- Regulatory Compliance: Track the adoption of silica-free products (ICON) and the impact of the Australian ban on long-term revenue mix in that region.
- Nasdaq Compliance: Confirm the company's ability to maintain the $1.00 minimum bid price to avoid delisting.
- Israeli Tax Benefits: Assess the risk of losing "Preferred Enterprise" tax benefits in Israel due to the closure of domestic manufacturing facilities and the shift to offshore production.